32.84 +0.37 (1.14%)
After hours: 6:50PM EDT
|Bid||32.32 x 800|
|Ask||32.83 x 4000|
|Day's range||31.75 - 32.83|
|52-week range||15.12 - 42.89|
|Beta (5Y monthly)||0.63|
|PE ratio (TTM)||22.95|
|Earnings date||19 Oct 2020 - 23 Oct 2020|
|Forward dividend & yield||1.12 (3.49%)|
|Ex-dividend date||30 Jul 2020|
|1y target est||28.50|
The pet pharmacy delivered solid revenue and earnings growth. But its bottom-line improvement wasn't quite good enough to impress analysts.
Welcome to the PetMed Express Incorporated, doing business as 1-800-PetMeds, Conference Call to review the financial results for the First Fiscal Quarter ended on June 30, 2020. At the request of the Company, this conference is being recorded. At this time, I would like to turn the call over to the Company's Chief Financial Officer, Mr. Bruce Rosenbloom.
Shares of PetMed Express (NASDAQ: PETS) were sinking 16.4% as of 11:24 a.m. EDT on Monday. PetMed delivered strong revenue and earnings growth, but the company's earnings of $0.39 per share narrowly missed the consensus analysts' estimate of $0.40. Its earnings in the first quarter jumped 47% year over year to $7.8 million, or $0.39 in diluted earnings per share.